PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 174 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $77,485 | +3.5% | 17,895 | -26.1% | 0.00% | 0.0% |
| Q1 2023 | $74,868 | -12.5% | 24,229 | +19.8% | 0.00% | 0.0% |
| Q4 2022 | $85,522 | -25.0% | 20,218 | +63.2% | 0.00% | -50.0% |
| Q2 2021 | $114,000 | +11.8% | 12,385 | +17.5% | 0.00% | 0.0% |
| Q1 2021 | $102,000 | -5.6% | 10,539 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $108,000 | +1.9% | 10,539 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $106,000 | -3.6% | 10,539 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $110,000 | +23.6% | 10,539 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $89,000 | -80.9% | 10,539 | -80.2% | 0.01% | -82.9% |
| Q4 2019 | $466,000 | -32.9% | 53,289 | -17.4% | 0.04% | -35.9% |
| Q3 2019 | $695,000 | -75.1% | 64,532 | +102.3% | 0.06% | -89.0% |
| Q2 2017 | $2,788,000 | – | 31,900 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |